MCK - McKesson - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58155Q1031

Pharmaceuticals, Medical-Surgical Supplies, Technology Solutions

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. Web URL: https://www.mckesson.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for MCK - McKesson  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for MCK - McKesson  - Stock Price & Dividends

MCK Stock Overview

Market Cap in USD 75,667m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1994-11-15

MCK Stock Ratings

Growth 5y 96.6
Fundamental 52.1
Dividend 57.2
Rel. Performance vs Sector 1.18
Analysts 4.28/5
Fair Price Momentum 731.76 USD
Fair Price DCF 737.16 USD

MCK Dividends

Dividend Yield 12m 0.41%
Yield on Cost 5y 1.83%
Dividends CAGR 5y 7.71%
Payout Consistency 97.4%

MCK Growth Ratios

Growth 12m 49.73%
Growth Correlation 12m 87%
Growth Correlation 3m 56%
CAGR 5y 34.51%
CAGR/Mean DD 5y 7.20
Sharpe Ratio 12m 2.47
Alpha vs SP500 12m 33.64
Beta vs SP500 5y weekly 0.69
ValueRay RSI 72.87
Volatility GJR Garch 1y 18.23%
Price / SMA 50 3.28%
Price / SMA 200 16.56%
Current Volume 634.1k
Average Volume 20d 660.8k

External Links for MCK Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of MCK stocks?
As of July 27, 2024, the stock is trading at USD 600.16 with a total of 634,064 shares traded.
Over the past week, the price has changed by +3.45%, over one month by +0.10%, over three months by +10.59% and over the past year by +49.91%.
What are the forecast for MCK stock price target?
According to ValueRays Forecast Model, MCK McKesson will be worth about 805.3 in July 2025. The stock is currently trading at 600.16. This means that the stock has a potential upside of +34.18%.
Issuer Forecast Upside
Wallstreet Target Price 612.6 2.07
Analysts Target Price 486.3 -19.0
ValueRay Target Price 805.3 34.2

McKesson Corporation: History, Business Segments, and Market Status

History of McKesson Corporation

McKesson Corporation, today a titan in the healthcare sector, has a rich history that traces back to 1833. Founded by John McKesson and Charles Olcott in New York City as Olcott & McKesson, it started off by selling therapeutic drugs and chemicals wholesale. Throughout the years, McKesson has evolved, undergoing numerous transformations and absorbing several entities to cement its place in the healthcare industry. This expansive timeline has seen McKesson transition from a simple drugstore to a global healthcare services and information technology company, exemplifying its adaptability and forward-thinking approach.

Core and Side Businesses of McKesson

Core Business

At the heart of McKesson's operations is its pharmaceutical distribution and healthcare services. The company stands as one of the largest distributors of pharmaceuticals in the world, supplying drugs, medical supplies, and health information technology (IT) products and services across multiple channels. This core segment focuses on improving supply chain efficiencies, reducing healthcare costs, and delivering better health outcomes.

Side Businesses

Alongside its primary focus, McKesson operates several side businesses, including medical surgical solutions, and various technology-based services aimed at enhancing pharmacy management, automating clinical workflows, and improving inventory management. Furthermore, McKesson is involved in retail pharmacy chains and specialty health services, catering to specific patient needs across oncology, rheumatology, and other fields. These diversified service areas exemplify McKesson’s commitment to addressing the comprehensive needs of the healthcare system.

Current Market Status

As of the latest updates in 2023, McKesson Corporation (NYSE:MCK) continues to be a dominant force in the healthcare supplier and technology market. With its strategic expansions and partnerships, the company has maintained a robust position in the market. McKesson's financial performance reflects its operational success, showcasing sustained revenue growth and a strong market capitalization. The company's ongoing efforts to innovate within the healthcare sector, combined with its commitment to corporate responsibility, position it well for continued success in addressing the dynamic needs of the healthcare industry.